Vedanta Wins Bid For Kauhari Diamond Block In Madhya Pradesh

Vedanta Ltd. has been declared the preferred bidder for the Kauhari Diamond Block in Madhya Pradesh. The company secured the bid with a final price offer of 1.10%, marking a strategic move into the diamond mining sector.

The mine spans 643.4169 hectares and is currently at the G4 exploration stage, indicating an early-phase assessment of its mineral potential.

Vedanta’s Bid and Regulatory Process

Vedanta emerged as the highest bidder in the auction process conducted by the Madhya Pradesh government for the grant of a composite licence for the Kauhari Diamond Block. 

The company’s selection as the preferred bidder is contingent upon meeting several regulatory requirements, including the payment of a performance bank guarantee, fulfilment of tender conditions, and obtaining necessary approvals from various government bodies. The finalisation of the licence will also require the execution of necessary agreements.

Exploration and Future Prospects

The G4 level of exploration indicates a reconnaissance stage, which involves large-scale geological mapping and airborne geophysical surveys to identify potential mineral deposits. This is an initial phase of exploration, and further assessment will determine the economic viability of diamond extraction from the block. 

As a leading global natural resources and technology conglomerate, Vedanta operates across India, South Africa, Liberia, and Namibia, and this move strengthens its position in the mining sector.

Vedanta Share Performance

As of February 24, 2025, at 9:20 AM, the shares of Vedanta are trading at ₹433.55 per share, reflecting a decline of 1.04% from the previous day’s closing price. Over the past month, the stock has registered a loss of 1.89%. The stock’s 52-week high stands at ₹526.95 per share while its 52-week low is ₹249.50 per share.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Tata AIA Life Unveils New Index Pension Fund for Retirement Savings Growth

Tata AIA Life Insurance has introduced its latest New Fund Offer (NFO), the ‘Multicap Momentum Quality Index Pension Fund’, designed to provide individuals with smarter, market-linked investment solutions. 

This fund aims to help investors build a strong retirement corpus while maintaining control over their financial future. It utilises a quant-based investment strategy to balance market growth opportunities with portfolio stability. The NFO is open for subscription starting today and will close on February 28, 2025.

Investment Strategy and Structure

The Multicap Momentum Quality Index Pension Fund is structured to invest in companies that align with the Multicap Momentum Quality 50 Index. It follows a well-defined asset allocation strategy to generate high returns with managed risk.

  • Investment Focus: Companies aligned with the Multicap Momentum Quality 50 Index
  • Asset Allocation: 80%-100% in equity and equity-related instruments, 0%-20% in cash & money market securities
  • Risk Profile: Designed to provide high returns with managed risk, ensuring stability
  • Fund Management Charge (FMC): 1.35% per annum

Key Benefits for Investors

The fund offers multiple advantages to investors, ensuring balanced growth and financial security.

  • Long-term Capital Growth: Invests in high-potential companies aligned with the Multicap Momentum Quality 50 Index
  • Smart Diversification: Exposure across large, mid, and small-cap stocks
  • Risk-Optimised Investing: Uses momentum and quality factors to select strong, high-growth stocks
  • Convenient Retirement Planning: Available through Tata AIA’s Smart Pension Secure plan with pension-linked benefits
  • Easy Access: Available online via Tata AIA’s website and digital platforms like Policybazaar, Tata Neu, and PhonePe

Curious about your SBI SIP returns? Get accurate estimates of your investment growth using our SBI SIP Calculator and stay ahead of your financial goals.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Zydus LifeSciences Gets USFDA Approval for Ibuprofen and Famotidine Tablets

Zydus Lifesciences Limited, formerly Cadila Healthcare Limited, is a leading Indian multinational pharmaceutical company headquartered in Ahmedabad, Gujarat. Founded in 1952 by Ramanbhai Patel and Indravadan Modi, it has grown into a global life sciences powerhouse with a presence in over 50 countries.

Approval from USFDA

In a significant regulatory milestone, Zydus Lifesciences has secured final approval from the United States Food and Drug Administration (USFDA) to manufacture Ibuprofen and Famotidine tablets (800 mg/26.6 mg). 

This novel combination therapy is indicated for the effective relief of symptoms associated with rheumatoid arthritis and osteoarthritis while concurrently mitigating the risk of upper gastrointestinal ulcers (gastric and/or duodenal) in patients undergoing ibuprofen treatment for these conditions. The production of these tablets will take place at the company’s state-of-the-art facility in the Special Economic Zone (SEZ), Ahmedabad.

The Ibuprofen and Famotidine tablets garnered annual sales of USD 3.6 million in the United States (IQVIA MAT December 2024). With this latest approval, Zydus Lifesciences now boasts an impressive portfolio of 415 approvals, having filed 483 Abbreviated New Drug Applications (ANDAs) since the inception of the filing process in FY 2003-04.

Zydus Lifesciences Q3 FY25 Results

The company delivered a stellar financial performance in Q3 FY25, with revenue soaring 17% year-on-year to ₹5,269.1 crore and net profit surging 30% to ₹1,023.5 crore. EBITDA witnessed a robust 26% growth, reaching ₹1,387.6 crore, with an enviable margin of 26.3%. Investments in research and development remained substantial at ₹503.1 crore (9.5% of revenue), while capital expenditure stood at ₹290.7 crore.

Segment-wise, the India formulations business recorded a steady 5% growth, generating ₹1,498.2 crore, whereas the U.S. formulations segment experienced a remarkable 30.8% surge to ₹2,409.6 crore. The consumer wellness division also posted a commendable 13% increase in revenue, amounting to ₹448.8 crore.

Share Price Performance 

At 10:18 AM on February 24, 2025, Zydus Lifesciences Ltd shares traded 1.36% higher at ₹897.36 per share on the NSE.

Use the Angel One stock trading app to stay ahead of the curve. Download it now to manage your investments and trades.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Rail Vikas Nigam Limited Awarded EPC Contract by South Western Railway

Rail Vikas Nigam Limited (RVNL), a premier Central Public Sector Enterprise under the Ministry of Railways, serves as the construction arm for project execution and transport infrastructure development across India.

Project from South Western Railway

On February 21, 2025, RVNL announced that it had emerged as the Lowest Bidder (L1) for a prestigious contract awarded by South Western Railway. The project entails the Engineering, Procurement, and Construction (EPC) for the design, supply, erection, testing, and commissioning of a 2×25 KV Overhead Electrification (OHE) and Power Supply (PSI) System between Rayadurga and Topavagada in the TK-RDG section.

Scope of the Project

The scope of work encompasses the establishment of Transmission Substations (TSS), Switching Posts (SPs), and Sectioning and Paralleling Posts (SSPs), along with comprehensive electrical general services, engineering, and telecommunication works. The project covers an expansive length of approximately 99.463 RKM / 114.145 TKM.

In adherence to SEBI guidelines, this project is domestic in nature and comes with a stipulated completion timeline of 18 months. The total contract value stands at an impressive ₹156.36 crore.

RVNL Q3 FY25 Financial Performance

On February 14, 2025, RVNL unveiled its Q3 FY25 financial results, reporting a net profit of ₹311.44 crore, reflecting a 13.14% decline from ₹358.57 crore in the corresponding quarter of the previous fiscal year. Revenue from operations stood at ₹4,567.38 crore, marking a 2.6% decrease compared to ₹4,689.33 crore year-on-year.

The company’s operating income for the quarter was ₹231.89 crore, a 5.07% dip from ₹244.27 crore in Q3 FY24. Meanwhile, the margin of earnings before interest, taxes, depreciation, and amortisation (EBITDA) remained largely stable at 5.2%, compared to 5.3% in the corresponding period last year.

Share Price Performance

At 10:17 AM on February 24, 2025, Rail Vikas Nigam Ltd shares traded 1.51% down at ₹366.10 per share on the NSE.

Maximise your trading potential with our user-friendly trading app. Get the Angel One share trading app now and trade efficiently!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

RailTel Wins Kavach Order from East Central Railway Worth ₹288 Crore

RailTel Corporation of India Ltd., a distinguished Miniratna Central Public Sector Enterprise (CPSE) under the aegis of the Ministry of Railways, Government of India, stands as one of the nation’s premier neutral telecom infrastructure providers.

Project Details

The Railway Ministry’s esteemed public sector undertaking, RailTel Corporation of India Ltd., has been awarded the prestigious Kavach tender for 71 stations spanning a 502-kilometre route across the Danapur and Sonpur divisions of the East Central Railway, according to an official company statement issued on Saturday.

“This remarkable achievement underscores RailTel’s unwavering commitment to bolstering railway safety and operational excellence through cutting-edge technology. The Kavach tender, valued at approximately ₹288 crore, ranks among RailTel’s most significant signalling projects. The implementation of this sophisticated system will not only fortify safety measures but also elevate the overall operational efficiency of the East Central Railway,” the statement affirmed.

About Kavach Technology 

Kavach, an indigenous Automatic Train Protection (ATP) system, is designed to avert train collisions by autonomously engaging the brakes should loco pilots fail to act in time. This pioneering technology plays a pivotal role in ensuring the seamless operation of trains, preventing red signal overshoots and potential collisions.

As per RailTel, this state-of-the-art technology will be deployed extensively across the East Central Railway, safeguarding an expansive railway network and enhancing the safety of millions of passengers.

Statement From Management 

“We are elated to have been entrusted with the implementation of the Kavach Project in the East Central Railway,” stated RailTel’s Chairman and Managing Director, Sanjai Kumar.

“The Kavach system represents a monumental advancement in railway safety, and we are resolute in our commitment to executing this project with the utmost precision and efficiency. Securing this tender is a testament to RailTel’s expertise and dedication to pioneering innovation in the railway sector,” he added.

Share Price Performance 

At 10:15 AM on February 24, 2025, RailTel Corporation of India Ltd shares traded at ₹311.85, up 2.08% per share on the NSE.

Join millions of happy investors and traders. Download the Angel One mutual fund app now and stay connected to the market wherever you are!

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Sensex Falls More Than 11,000 Points from September Peak, Now Trading Below 75,000

On Monday, February 24, 2025, the BSE Sensex registered a significant fall in early deals. Trading at 74,525 points as of 10:58 AM, the index slipped below the 75,000 mark with a decline of 1.05%. This downturn is set against a backdrop of fragile global cues that have unsettled investor sentiment.

Global Influences and FII Activity

A confluence of external factors and persistent selling by foreign institutional investors (FIIs) has contributed to the recent slide. Notably, FIIs have emerged as net sellers totalling approximately ₹1.24 lakh crore in the current calendar year as of February 21, 2025. Such selling pressure has further dampened market vigour and contributed to the overall decline.

Sectoral Performance

While the BSE FMCG sector has managed to hold its ground, nearly all other sectors have traded in the red. Particularly, the BSE IT and BSE Telecom sectors experienced pronounced losses, falling by 2.19% and 1.94% respectively. The market’s advance-decline ratio is also concerning, with only six stocks advancing in contrast to 24 that have declined.

Key Contributors: Pullers and Draggers

The market movement has been notably influenced by the performance of specific stocks. HDFC Bank, Infosys, and ICICI Bank have been among the top draggers, exerting downward pressure on the index. Conversely, stocks such as M&M and ITC have managed to act as pullers, offering slight relief amid the general downturn.

Historical Perspective

In comparative terms, the current decline adds to a larger narrative. The BSE Sensex, which peaked in September last year, is now trailing by over 11,000 points from its highs. February’s performance, with a fall of 3.78%, marks the most significant drop in the month since the 2020 decline of 5.96%. On a year-to-date basis, the index is down by 4.63%, which offers a stark illustration of the prevailing market conditions.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Nifty50 Records Worst February Since COVID: Falls Below 22,600 as India VIX Rises

Recent developments in the US markets have reverberated across global indices. Concerns over softening consumer demand and uncertainty related to tariffs contributed to a sharp sell-off. Notably, US consumer sentiment reached a 15‑month low in February, thereby adding pressure on international investors and influencing market moods worldwide.

NSE Performance on Monday, February 24, 2025

The NSE benchmark Nifty50 index opened in negative territory for the 5th consecutive session on Monday, February 24, 2025. By 10:36 AM, the majority of sectors were trading in the red. This downward trend coincided with heightened global uncertainties and a cautious approach from market participants.

Sector Performance

Within the broad market decline, certain sectors managed to exhibit modest gains. Nifty Pharma and Auto registered slight increases of 0.22% and 0.08%, respectively. Conversely, Nifty IT emerged as the top loser, plunging nearly 2.5% as all its constituent stocks recorded losses. Overall, only 10 stocks were trading in green, indicating widespread selling pressure across most segments.

Key draggers in the index included prominent names such as HDFC Bank, Infosys, and ICICI Bank. Additionally, companies like M&M and Maruti featured among the top pullers, underscoring the challenges faced by even the most established entities during this period of market stress.

Historical Context and Year-to-Date Trends

For the month of February 2025, the Nifty50 has recorded a nearly 4% decline – the steepest monthly fall since 2020, when the index experienced a 6.36% drop. This marks the sharpest contraction since 2016. On a year-to-date basis, the index is down 4.56%. Moreover, from its September high of 26,277, the Nifty50 has seen a reduction of over 14%, reflecting a pronounced market correction over recent months.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Save Interest on Home Loan by Over ₹26 Lakhs by Doing This with Your EMI

The financial year 2025-26 brings double good news for salaried individuals. Finance Minister Nirmala Sitharaman has announced generous income tax cuts, boosting disposable income for many taxpayers. Additionally, annual increments and performance bonuses typically disbursed around this time further contribute to higher earnings.

For home loan borrowers, this extra cash presents a valuable opportunity to reduce liabilities and save significantly on interest payments. With the Reserve Bank of India (RBI) cutting the repo rate by 25 basis points (bps) on February 7, making the right financial decision can mean saving lakhs over the tenure of your home loan.

Why You Should Retain or Increase Your EMI Instead of Reducing It

A common reaction to lower interest rates is to reduce the Equated Monthly Instalment (EMI) to free up more cash flow. However, this approach is not always the best financial move. When interest rates decline, banks typically retain the EMI amount and shorten the tenure of the loan unless a borrower specifically requests a lower EMI.

While a lower EMI might seem appealing, it comes at the cost of paying more interest over time. By maintaining the same EMI or even increasing it slightly, borrowers can significantly reduce their loan tenure and total interest outgo.

For example, let’s consider a borrower who has taken a 20-year home loan of ₹50 lakh at an interest rate of 8.5% per annum. If they have already paid 12 EMIs by March and their interest rate drops to 8.25% from April, the savings potential is remarkable:

  • By retaining the EMI, the borrower will save ₹8,114 per lakh over the tenure.
  • If they reduce the EMI, the savings drop to ₹3,472 per lakh.
  • That’s a 133% higher savings in the first scenario.

Clearly, opting for a tenure reduction instead of lowering the EMI results in substantial interest savings.

The Impact of Increasing EMI Payments

When the RBI hikes repo rates, banks are required to provide borrowers with options such as increasing their EMIs, extending the loan tenure, or using a combination of both. Similarly, in a falling rate environment, it is beneficial for borrowers to proactively approach their banks to increase their EMI or make a part-prepayment.

By increasing the EMI by just ₹5,000, a borrower can achieve significant financial benefits:

  • Loan tenure reduces from 300 months (25 years) to 208 months (17.3 years).
  • Interest outgo drops from ₹70.78 lakh to ₹44.13 lakh, saving a staggering ₹26.65 lakh.
  • A total of 92 EMIs are saved, meaning the borrower achieves debt freedom much sooner.

Considering that a salaried individual earning ₹25 lakh per year will save around ₹1.14 lakh annually due to tax cuts, these additional savings can be directly redirected towards an EMI hike, making it an excellent strategy to accelerate loan repayment.

Comparing Different Scenarios: How Much Can You Save?

The following table illustrates the financial impact of different approaches to managing a home loan after the RBI’s rate cut:

  Rate type Rate of interest Repayment tenure (months) Loan amount (₹) Monthly EMI (₹) Overall interest payable (₹) Number of EMIs saved Overall interest saved (₹)
Original scenario (Pre-Repo reduction) Floating 8.5 300 50,00,000 40,261 70,78,406    
EMI reduced (Tenure retained) Floating 8.25 300 50,00,000 39,423 68,26,752   2,51,654
EMI retained (Tenure shortened) Floating 8.25 281 50,00,000 40,261 62,98,898 19 7,79,509
EMI increased (by ₹5,000) Floating 8.25 208 50,00,000 45,261 44,13,372 92 26,65,034

The Impact of Increasing EMI Payments

When the RBI hikes repo rates, banks are required to provide borrowers with options such as increasing their EMIs, extending the loan tenure, or using a combination of both. Similarly, in a falling rate environment, it is beneficial for borrowers to proactively approach their banks to increase their EMI or make a part-prepayment.

By increasing the EMI by just ₹5,000, a borrower can achieve significant financial benefits:

  • Loan tenure reduces from 300 months (25 years) to 208 months (17.3 years).
  • Interest outgo drops from ₹70.78 lakh to ₹44.13 lakh, saving a staggering ₹26.65 lakh.
  • A total of 92 EMIs are saved, meaning the borrower achieves debt freedom much sooner.

Considering that a salaried individual earning ₹25 lakh per year will save around ₹1.14 lakh annually due to tax cuts, these additional savings can be directly redirected towards an EMI hike, making it an excellent strategy to accelerate loan repayment.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Ayushman Bharat in Delhi: ₹10 Lakh Health Insurance – Who’s Eligible and How to Apply?

The Ayushman Bharat health insurance scheme has been approved for implementation in Delhi. Chief Minister Rekha Gupta announced the decision after the first Cabinet meeting on February 20. The scheme, which was not previously available in Delhi, will now provide ₹10 lakh health insurance coverage per family, with ₹5 lakh each from the central and Delhi governments.

What the Scheme Covers

Under this scheme, eligible beneficiaries can avail of cashless treatment for secondary and tertiary healthcare in empanelled hospitals across India. It includes expenses for hospitalization, surgeries, and critical illnesses.

The scheme has two main components:

  1. Health and Wellness Centers (HWCs) – These centres provide free primary healthcare, essential medicines, diagnostic tests, and disease screenings. The government aims to set up 1.5 lakh HWCs across the country.
  2. Pradhan Mantri Jan Arogya Yojana (PMJAY) – This covers hospitalization expenses, allowing low-income families to access treatment without financial burden.

Check Your Eligibility for Ayushman Bharat in Delhi

The scheme is designed to benefit:

  • Low-income families are in need of financial assistance for healthcare.
  • Delhi residents who were previously not covered under Ayushman Bharat.
  • Senior citizens aged 70 and above, regardless of income.

How to Apply for Ayushman Bharat Scheme in Delhi?

The registration process for Ayushman Bharat in Delhi can be completed online. Steps to apply:

  1. Visit the National Health Authority (NHA) beneficiary portal.
  2. Enter your mobile number and authenticate via OTP.
  3. Provide Aadhaar details and complete KYC verification.
  4. Download the Ayushman Bharat card once the application is approved.

Alternatively, applicants can register using the Ayushman App or visit Common Service Centers (CSCs) and hospitals for assistance.

With the scheme now available in Delhi, eligible residents can enroll and access healthcare services under this government initiative. The authorities have stated that they plan for quick implementation to make sure that beneficiaries can start using the scheme soon.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

Sovereign Gold Bonds: Evaluating the Secondary Market Option

The Indian government has halted the issuance of Sovereign Gold Bonds (SGBs), raising concerns among investors who viewed them as a secure and rewarding gold investment avenue. With no fresh issuances, the only way to acquire SGBs is through the secondary market. However, potential investors must assess various factors before making a purchase.

Current Market Conditions and Investment Considerations

The SGBs available in the secondary market are currently trading at a minor discount to the prevailing gold price.

This makes them a more attractive option than direct gold purchases, particularly as they also provide an additional interest component. Investors should target issues that are trading significantly below their nominal value on stock exchanges such as NSE and BSE to maximise returns.

One must avoid acquiring SGBs at excessively high premiums and should carefully examine trading volumes. Low liquidity can result in difficulties when attempting to sell before maturity, necessitating a long-term holding strategy.

Alternative Gold Investment Options

There are alternative gold investment options such as Gold ETFs or Gold Mutual Funds. These alternatives offer greater liquidity, tax efficiency, and avoid GST implications, unlike physical or digital gold. Additionally, investors can choose Systematic Investment Plans (SIPs) in Gold Mutual Funds, making gold investment more convenient and accessible.

For those with specific financial objectives, SGB purchases from the secondary market can align well with their investment goals. 

However, the remaining tenure of the bond should match the investor’s financial plan. It is important to evaluate the SGB price against the prevailing gold market rate, considering the market’s liquidity constraints, and assessing the post-tax payout before making a decision.

Key Factors to Consider Before Investing in Secondary Market SGBs

Here are crucial factors to evaluate when purchasing SGBs through the secondary market:

  • Maturity Date: Each SGB issue has a fixed maturity period of eight years. Bonds closer to maturity may offer better yields but provide fewer interest payments. Detailed maturity dates can be found on the RBI website.
  • Interest Yield: SGBs offer a 2.5% annual interest, payable semi-annually, based on the nominal issue price, not the market purchase price. Current 2031 SGBs yield approximately 1.4% due to their high market price.
  • Liquidity and Pricing Strategy: The secondary market often has low liquidity, leading to wide bid-ask spreads. Investors should use limit orders instead of market orders to avoid excessive premiums and be prepared for delayed execution.
  • Tax Implications: Capital gains on SGBs held until maturity are tax-free. However, selling before maturity incurs capital gains tax—long-term gains (held over 12 months) are taxed at 12.5% without indexation, while short-term gains are taxed as per applicable income tax slabs. Interest income is taxable at the investor’s slab rate.
  • Older SGB Issues: Buying deeply discounted older SGBs may not always be beneficial as they may have missed recent gold price rallies and could indicate liquidity issues with that specific issuance.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.